A case-control study published in JAMA Pediatrics reports a relationship between certain aberrant metabolic biomarkers at birth and sudden infant death syndrome (SIDS). Although the research is preliminary and no screening test for this syndrome is yet available, the researchers believe their study is an important step toward integrating metabolic and genetic markers to identify infants at higher risk of sudden death.
Georgia Sarquella-Brugada - muerte súbita EN
Georgia Sarquella Brugada
Paediatric cardiologist and head of the Arrhythmia Unit at the Sant Joan de Déu Hospital in Barcelona
The study is interesting, it gives value to neonatal metabolic tests, highlighting what we know and experience in our day-to-day practice. It reinforces the fact that neonatal metabolic screening tests are important.
The fight against sudden pediatric death must be approached from all perspectives. This study emphasizes the importance of metabolic diseases as a notable cause.
We hope that we can also give value to neonatal electrocardiographic evaluation to detect early the risks of sudden death due to hereditary arrhythmias.
- Research article
- Peer reviewed
- Case study
- People
Scott P. Oltman et al.
- Research article
- Peer reviewed
- Case study
- People
